GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $5,107,000 | -36.0% | 44,188 | -46.1% | 0.00% | -40.0% |
| Q3 2020 | $7,981,000 | +23.5% | 82,031 | +55.9% | 0.01% | -28.6% |
| Q2 2020 | $6,462,000 | +218.2% | 52,608 | +127.7% | 0.01% | +133.3% |
| Q1 2020 | $2,031,000 | +230.8% | 23,100 | +290.5% | 0.00% | – |
| Q4 2019 | $614,000 | -90.0% | 5,916 | -88.9% | 0.00% | -100.0% |
| Q3 2019 | $6,133,000 | +699.6% | 53,317 | +1098.4% | 0.01% | +600.0% |
| Q2 2019 | $767,000 | -92.1% | 4,449 | -92.3% | 0.00% | -90.9% |
| Q1 2019 | $9,724,000 | +557.0% | 57,691 | +279.5% | 0.01% | +450.0% |
| Q4 2018 | $1,480,000 | +22.9% | 15,200 | +118.1% | 0.00% | +100.0% |
| Q3 2018 | $1,204,000 | +692.1% | 6,968 | +540.4% | 0.00% | – |
| Q2 2018 | $152,000 | -99.1% | 1,088 | -99.2% | 0.00% | -100.0% |
| Q4 2016 | $16,040,000 | +35.3% | 143,533 | +60.7% | 0.03% | +40.9% |
| Q3 2016 | $11,857,000 | +1194.4% | 89,333 | +793.3% | 0.02% | +1000.0% |
| Q2 2016 | $916,000 | -86.2% | 10,000 | -89.5% | 0.00% | -85.7% |
| Q4 2015 | $6,646,000 | – | 95,690 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|